The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be Investigated

NCT03131232 · clinicaltrials.gov ↗
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

RWTH Aachen University